thiazolyl blue has been researched along with panaxydol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hai, J; Lin, Q; Lu, Y; Yi, J; Zhang, H | 1 |
| Cai, JX; Fu, SL; Hang, Q; Jiang, XY; Lin, L; Lu, PL; Lu, Y; Nie, BM; Yang, LM | 1 |
2 other study(ies) available for thiazolyl blue and panaxydol
| Article | Year |
|---|---|
Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells.
Topics: Animals; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Size; Diynes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Fatty Alcohols; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioma; Proliferating Cell Nuclear Antigen; Rats; Tetrazolium Salts; Thiazoles; Time Factors | 2008 |
Panaxydol and panaxynol protect cultured cortical neurons against Abeta25-35-induced toxicity.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; bcl-2-Associated X Protein; Calcium; Cell Death; Cells, Cultured; Cerebral Cortex; Diynes; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Fatty Alcohols; Gene Expression Regulation; In Situ Nick-End Labeling; Microscopy, Confocal; Neurons; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Rats; Tetrazolium Salts; Thiazoles; Time Factors | 2008 |